Physician profile
Tracy Barr
NPI 1770654196
$1,302.91
in general payments reported to CMS, 2019-2025
20 companies · $492 in 2025
The $492 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $63.60 · 2021: $125 · 2022: $205 · 2023: $82.05 · 2024: $213 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $256.18 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $177.48 | 2023-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $149.77 | 2019-2024 | |
| Sanofi Pasteur INC. | $107.10 | 2023-2025 | |
| Abbott Laboratories | $74.25 | 2019 | |
| Merck Sharp & Dohme LLC | $71.18 | 2023-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Cranial Technologies, INC | $58.89 | 2020-2021 | |
| Tris Pharma INC | $52.71 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $46.54 | 2024-2025 | Relexxii |
| Collegium Pharmaceutical, INC. | $42.78 | 2025 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $41.13 | 2025 | Neffy |
| Neurelis, INC. | $37.16 | 2025 | Valtoco |
| Neos Therapeutics, LP | $31.39 | 2019-2024 | Adzenys Xr-Odt |
| Lnhc, INC | $30.00 | 2025 | Zelsuvmi |
| Takeda Pharmaceuticals U.S.A., INC. | $27.76 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $22.64 | 2025 | Bexsero |
| Sanofi-Aventis U.S. LLC | $22.15 | 2025 | |
| Kaleo, INC. | $19.72 | 2022 | |
| Verrica Pharmaceuticals INC. | $18.82 | 2025 | Ycanth |
| Genentech USA, INC. | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.